UCK2 and cancer: For some HCCs with lower activity of dCK to begin with, interim treatment with other drugs that interact with pyrimidine metabolism, or with uridine-cytidine kinase 2 (UCK2)-dependent drugs, might at least partially restore dCK activity and possibly increase CFA uptake in those cancers with initially low CFA uptake.